Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 2/20 | 0.75 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.75 |
| ▸ | USP2 | O75604 | 1/20 | 0.75 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.75 |
| ▸ | LMNA | P02545 | 1/20 | 0.75 |
| ▸ | MMP9 | P14780 | 1/20 | 0.75 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.75 |
| ▸ | CA1 | P00915 | 15/20 | 0.64 |
| ▸ | CA2 | P00918 | 15/20 | 0.64 |
| ▸ | CA9 | Q16790 | 13/20 | 0.64 |
| ▸ | CA12 | O43570 | 4/20 | 0.64 |
| ▸ | CA7 | P43166 | 4/20 | 0.64 |
| ▸ | CA14 | Q9ULX7 | 4/20 | 0.64 |
| ▸ | CA3 | P07451 | 3/20 | 0.64 |
| ▸ | CA4 | P22748 | 3/20 | 0.64 |
| ▸ | CA6 | P23280 | 3/20 | 0.64 |
| ▸ | CA5A | P35218 | 3/20 | 0.64 |
| ▸ | CA5B | Q9Y2D0 | 3/20 | 0.64 |
| ▸ | RECQL | P46063 | 2/20 | 0.61 |
| ▸ | GLA | P06280 | 1/20 | 0.61 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11748392 | 1.00 | TSHR (0.75) | TSHRKDM4EUSP2ALDH1A1LMNA | |
| SCHEMBL5605250 | 1.00 | TSHR (0.75) | TSHRKDM4EUSP2ALDH1A1LMNA | |
| Methanesulfonic Acid Dodecyl Ester SCHEMBL2223590 | 1.00 | TSHR (0.75) | TSHRKDM4EUSP2ALDH1A1LMNA | |
| SCHEMBL7726676 | 1.00 | TSHR (0.75) | TSHRKDM4EUSP2ALDH1A1LMNA | |
| SCHEMBL1899016 | 1.00 | TSHR (0.75) | TSHRKDM4EUSP2ALDH1A1LMNA | |
| SCHEMBL11225069 | 1.00 | TSHR (0.75) | TSHRKDM4EUSP2ALDH1A1LMNA | |
| SCHEMBL1443722 | 1.00 | TSHR (0.75) | TSHRKDM4EUSP2ALDH1A1LMNA | |
| SCHEMBL908020 | 1.00 | TSHR (0.75) | TSHRKDM4EUSP2ALDH1A1LMNA | |
| SCHEMBL3092383 | 1.00 | TSHR (0.75) | TSHRKDM4EUSP2ALDH1A1LMNA | |
| SCHEMBL11236129 | 1.00 | TSHR (0.75) | TSHRKDM4EUSP2ALDH1A1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 100 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118652295-A | Preparation method of 2' -hexadecyloxy guanosine derivative | 安徽美华高科制药有限公司 | 2024-09-17 | — | — | CN | claimed |
| CN-115052854-A | Salt of tranexamic acid ester | 阿克特拉配料公司 | 2022-09-13 | — | — | CN | claimed |
| CN-103209985-B | Phosphonate derivatives and methods of synthesis thereof | 奇默里克斯公司 | 2016-08-24 | — | — | CN | claimed |
| US-20140046085-A1 | Phosphonate Ester Derivatives and Methods of Synthesis Thereof | CHIMERIX, INC. (US) | 2014-02-13 | — | — | US | claimed |
| CN-103209985-A | Phosphonate derivatives and methods of synthesis thereof | CHIMERIX INC | 2013-07-17 | — | — | CN | claimed |
| EP-2611818-A2 | PHOSPHONATE ESTER DERIVATIVES AND METHODS OF SYNTHESIS THEREOF | Chimerix, Inc. (US) | 2013-07-10 | — | — | EP | claimed |
| WO-2012031045-A2 | PHOSPHONATE ESTER DERIVATIVES AND METHODS OF SYNTHESIS THEREOF | CHIMERIX, INC. (US) | 2012-03-08 | — | — | WO | claimed |
| CN-1978431-A | Ionic liquid using quaternary ammonium caprolactam as cation and its preparing method | LANZHOU CHEM PHYS INST (CN) | 2007-06-13 | — | — | CN | claimed |
| CN-118652295-A | Preparation method of 2' -hexadecyloxy guanosine derivative | 安徽美华高科制药有限公司 | 2024-09-17 | — | — | CN | disclosed |
| US-11603380-B2 | Antiviral acyclonucleoside analogues for use in treating a viral infection | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) | 2023-03-14 | — | — | US | disclosed |
| US-20210079031-A1 | NEW ANTIVIRAL ACYCLONUCLEOSIDE ANALOGUES | NEOVIRTECH (FR) | 2021-03-18 | — | — | US | disclosed |
| EP-3784680-A1 | NEW ANTIVIRAL ACYCLONUCLEOSIDE ANALOGUES | Centre national de la recherche scientifique (FR) | 2021-03-03 | — | — | EP | disclosed |
| US-20190322958-A1 | Lubricant Composition | BASF SE (DE) | 2019-10-24 | — | — | US | disclosed |
| US-20190322958-A1 | Lubricant Composition | BASF SE (DE) | 2019-10-24 | — | — | US | disclosed |
| US-5138067-A | PAF antagonists, antithrombotic, antivasoconstricting, antibronchoconstricting or antitumor agents | SHIONOGI & CO. LTD. (JP) | 1992-08-11 | — | — | US | disclosed |
| US-5087721-A | Tumor-specific; for diagnosis and therapy | THE UNIVERSITY OF MICHIGAN (US) | 1992-02-11 | — | — | US | disclosed |
| US-5047540-A | Platelet Activating Factor Antagonists and Antitumor Agents | SHIONOGI & CO., LTD. (JP) | 1991-09-10 | — | — | US | disclosed |
| US-4965391-A | Tumor specific | THE UNIVERSITY OF MICHIGAN (US) | 1990-10-23 | — | — | US | disclosed |
| EP-0321296-A1 | Lipid derivatives their preparation and use | SHIONOGI SEIYAKU KABUSHIKI KAISHA trading under the name of SHIONOGI & CO. LTD. (JP) | 1989-06-21 | — | — | EP | disclosed |
| EP-0072531-A1 | Derivatives of cyclophosphamide, process for their preparation and their use | Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) | 1983-02-23 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11603380-B2 | Antiviral acyclonucleoside analogues for use in treating a viral infection | TYMP, EIF2AK2, ENTPD5 | TSHR 4665/4885KDM4E 3270/4885USP2 3819/4885 |
| US-20210079031-A1 | NEW ANTIVIRAL ACYCLONUCLEOSIDE ANALOGUES | TYMP, EIF2AK2, PNP | TSHR 4758/4885KDM4E 3588/4885USP2 3968/4885 |
| US-20140046085-A1 | Phosphonate Ester Derivatives and Methods of Synthesis Thereof | PHOSPHO1, PIK3CA, PNP | TSHR 3965/4885KDM4E 1612/4885USP2 4050/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.